Published in Infect Agent Cancer on November 20, 2012
Role of viruses in the development of breast cancer. Infect Agent Cancer (2013) 0.86
Human papillomavirus infection and risk of breast cancer: a meta-analysis of case-control studies. Infect Agent Cancer (2016) 0.82
Pathogen-driven cancers and emerging immune therapeutic strategies. Cancer Immunol Res (2014) 0.78
The effects of antiviral treatment on breast cancer cell line. Infect Agent Cancer (2017) 0.75
Enhancing US-Japan cooperation to combat antimicrobial resistance. Biosecur Bioterror (2014) 0.75
Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev (2004) 9.28
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med (2007) 7.91
Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med (1971) 3.82
Tregs and rethinking cancer immunotherapy. J Clin Invest (2007) 3.77
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis (2003) 3.53
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone Marrow Transplant (2010) 3.46
Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med (1981) 3.19
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis (2009) 3.12
Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells. PLoS One (2009) 2.82
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood (2003) 2.41
Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proc Natl Acad Sci U S A (2004) 2.32
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood (2009) 2.31
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood (2001) 1.92
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest (2011) 1.87
Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood (2007) 1.85
Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis (2002) 1.80
Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant (2007) 1.77
Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis (2004) 1.70
Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med (1995) 1.67
Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis (1999) 1.66
How bacteria could cause cancer: one step at a time. Trends Microbiol (2002) 1.60
Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis (2004) 1.48
Anticancer activity of the antibiotic clioquinol. Cancer Res (2005) 1.47
Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study. Dig Liver Dis (2008) 1.46
Targeting HSP90 for cancer therapy. Br J Cancer (2009) 1.44
17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells. Blood (2003) 1.32
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett (2010) 1.31
Influenza immunization of adult patients with malignant diseases. Ann Intern Med (1977) 1.28
Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer (2000) 1.26
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother (2008) 1.26
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation. Br J Haematol (2011) 1.25
Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond? Leuk Lymphoma (2010) 1.20
Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer. Clin Cancer Res (2011) 1.20
Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention. Cancer Biol Ther (2010) 1.19
Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study. Ann Intern Med (1983) 1.18
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant (2007) 1.17
Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer (2002) 1.12
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives. Virus Res (2001) 1.11
Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. Transpl Infect Dis (2007) 1.07
Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation. Clin Infect Dis (2007) 1.05
Respiratory virus infections in adults with hematologic malignancies: a prospective study. Clin Infect Dis (2002) 1.04
Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma. J Immunother (2012) 1.04
Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin. Br J Cancer (2009) 1.02
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML). J Infect (2007) 0.97
Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma. J Infect Dis (2011) 0.97
Radiosensitization effect of zidovudine on human malignant glioma cells. Biochem Biophys Res Commun (2007) 0.97
Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.96
Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas. Cancer Res (1999) 0.96
Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study. Clin Infect Dis (2007) 0.96
Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer (2008) 0.96
Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae. Med Oncol (2002) 0.95
Thiazole antibiotics against breast cancer. Cell Cycle (2010) 0.93
Emergence of MRSA in positive blood cultures from patients with febrile neutropenia--a cause for concern. Support Care Cancer (2008) 0.93
Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy. J Infect Dis (1990) 0.92
Does antiviral therapy prevent hepatocellular carcinoma? Antivir Ther (2011) 0.92
Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Bone Marrow Transplant (2002) 0.90
Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. Int J Oncol (2003) 0.90
Telomeres, telomerase, and apoptosis. Biochem Cell Biol (2004) 0.89
Anti-CD20 monoclonal antibody (Rituximab) and Cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement. Onkologie (2001) 0.89
A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients. J Antimicrob Chemother (1992) 0.88
Acyclovir inhibition of IDO to decrease Tregs as a glioblastoma treatment adjunct. J Neuroinflammation (2010) 0.85
Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanism. Free Radic Biol Med (2008) 0.84
Antitumor activity of common antibiotics against superficial bladder cancer. Urology (2004) 0.84
Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells. Br J Cancer (2006) 0.83
Infections in hematological malignancies. Dis Mon (2012) 0.82
Safety and efficacy of activated transfected killer cells for neutropenic fungal infections. J Infect Dis (2010) 0.82
Treatment of locally recurrent Epstein-Barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir. J Med Virol (2008) 0.81
Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer. Urology (1999) 0.80
Antiviral approaches for cancers related to Epstein-Barr virus and human papillomavirus. Lancet Oncol (2001) 0.79
Chemotherapy-induced neutropenia in lung cancer patients: the role of antibiotic prophylaxis. Cancer Lett (2011) 0.78
Inhibition of Helicobacter pylori growth and its cytotoxicity by 2-hydroxy 4-methoxy benzaldehyde of Decalepis hamiltonii (Wight & Arn); a new functional attribute. Biochimie (2010) 0.77
Advances in antiviral therapy. Dermatol Clin (2005) 0.77
Antibiotic use and risk of gynecological cancer. Eur J Obstet Gynecol Reprod Biol (2011) 0.76
Outcome of combination antiviral therapy in chronic hepatitis C virus infection during therapy of acute lymphoblastic leukemia. Saudi J Gastroenterol (2011) 0.76
In vivo modulation of angiogenic gene expression by acyclic nucleoside phosphonates PMEDAP and PMEG. Anticancer Res (2009) 0.76
Implication of human herpesviruses in oncogenesis through immune evasion and supression. Infect Agent Cancer (2014) 0.87
Chick embryo extract demethylates tumor suppressor genes in osteosarcoma cells. Clin Orthop Relat Res (2014) 0.85
Childhood cancers: what is a possible role of infectious agents? Infect Agent Cancer (2013) 0.80